IK1 inhibitor PA-6
CAS: 500715-03-7
Ref. 3D-AVA71503
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
IK1 inhibitors have been shown to reduce the size of the atria in Sprague-Dawley rats. The effect is dose-dependent and reversible. This effect is caused by a reduction in the activation energy of the cardiac myocytes, which leads to a change in the kinetics of ion channels, as well as changes in intracellular calcium levels. IK1 inhibitors are polymers that contain an array of hydrophilic and hydrophobic segments. This polymer matrix has been shown to be effective for drug delivery to the heart, lungs, and other organs. IK1 inhibitor PA-6 has been shown to be effective for controlling water vapor transport from surfaces due to its high surface methodology and low viscosity properties.
Chemical properties
Technical inquiry about: 3D-AVA71503 IK1 inhibitor PA-6
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
